Gadoliniumtoxicity.org

07/08/2026

Deleterious Effects of Gadolinium in the Bone Marrow:
- Marrow hypoplasia and anaemia
- Leukopenia
- Hypophophataemia
- Marrow shortening
- Bone marrow infarction
- Increased Gd T1 hyperintensity on subsequent Mris

Gd and the Bone Marrow:
1. Gadolinium depositis in the bone marrow and has a predilection for doing so
2. Gadolinium is toxic to the bone marrow and marrow producing blood cells,
3. Gadolinium adversely affects calcium phosphate homeostasis in bone
4. Gadolinium structurally impaired Bone Marrow integrity

Objective Monthly scanning with triple-dose gadopentetate dimeglumine has been shown to be associated with progressive increases in bone T1 hyperintensity, hypo...

31/07/2026

This review examines how gadolinium (Gd) from contrast agents accumulates in the brain,. It finds that linear gadolinium-based agents stay longer in the brain and clear more slowly than macrocyclic ones, with Gd mainly found in deep gray matter. Prolonged exposure or preexisting health issues can increase neurotoxic risks, leading to deficits. Pain and sensory issues are common with linear agents.

31/07/2026

In addition to NSF being recognized as the foundational disease of gadolinium-related complications, the widespread acknowledgment of tissue gadolinium retention in all patients, REGARDLESS OF KIDNEY FUNCTION, soon followed. Gadolinium underlies the pathogenesis of GADOLINIUM-INDUCED SYSTEMIC FIBROSIS

https://journals.lww.com/cjasn/fulltext/9900/gadolinium_based_contrast_agents_and_the_theater.928.aspx

22/06/2026

Systemic fibrosis caused by Gadolinium in a patient during a transient period of renal insufficiency

19/06/2026

Another case of gadolinium toxicity with fibrocyte infiltration of the deep dermis and adipose layers in a patient with normal renal function.

19/06/2026

Our results, in contradiction to published literature, suggest that in patients with normal renal function, exposure to GBCAs in extremely high cumulative doses can lead to significant gadolinium deposition in the skin. This finding is in line with more recent reports of gadolinium deposition in the brain of patients with normal renal function.

Image shows the typical CD34 fibrocyte staining in the adipose tissue indicating gadolinium induced fibrosis

17/06/2026

DAILY MAIL - JIUNE 16th 2026 : GADOLINIUM SCANDAL EXPOSED

10/05/2026

In order to get serum gadolinium measured, the MD can order CPT code 83018, which as of May 2025 now includes Gadolinium.

09/05/2026

Safety concerns about Gadolinium contrast agents were raised for patients with normal kidney function in 2014, when researchers discovered that gadolinium could remain in patients’ brains and could accumulate with each additional dose of contrast that they received. Gadolinium has been found in bone, skin, and other organs and tissues of patients with normal kidney function.

https://www.center4research.org/health-risks-of-gbcas/?utm_source=chatgpt.com

09/05/2026

Gadolinium Damages the Small Blood Vessels Nailfold capillaroscopy:

The widespread occurrence of adverse alterations in the microcirculation, seen using nailfold capillaroscopy, is extensively found in multiple syndromes sharing the common injury of intensely damaged endothelium. For further info see 2025 review paper on this technique: https://www.preprints.org/manuscript/202505.2356

These diseases include systemic sclerosis, long covid, and raynauds, amongst others.

Is Gadolinium toxicity microvascular injury ready to be added to this list ? An example of a gadolinium toxic patient with abnormal nail-fold capillaroscopy is shown below. Studies could be done on affected patients, as microvascular injury is likely to be a central mechanism of damage in Gadolinium toxicity.

Gadolinium toxic patient with abnormal nailfold capillaroscopy, showing:
- vessel dropout
- vessel tortuosity
- vessel sclerosis / thickening